SciSparc Ltd. (NASDAQ:SPRC – Get Free Report) shot up 12.9% on Thursday . The stock traded as high as $0.35 and last traded at $0.35. 1,317,413 shares traded hands during mid-day trading, a decline of 68% from the average session volume of 4,141,202 shares. The stock had previously closed at $0.31.
SciSparc Trading Up 12.9 %
The stock has a 50 day moving average of $0.31 and a 200-day moving average of $0.36.
About SciSparc
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.
Featured Stories
- Five stocks we like better than SciSparc
- How to Use the MarketBeat Stock Screener
- IBM’s AI Offensive: Assessing IBM’s Path to Renewed Growth
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Rockwell Automation: Tailwinds From Onshoring U.S. Production
- The Significance of Brokerage Rankings in Stock Selection
- Is Energy Transfer Undervalued or a Value Trap?
Receive News & Ratings for SciSparc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SciSparc and related companies with MarketBeat.com's FREE daily email newsletter.
